Global Human NK Cell Isolation Kit Market Outlook, In‑Depth Analysis & Forecast to 2032

Table of Contents

1 Study Coverage
    1.1 Introduction to Human NK Cell Isolation Kit: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global Human NK Cell Isolation Kit Market Size by Type, 2021 vs 2025 vs 2032
        1.2.2 1 x 10^8 Cells
        1.2.3 1 x 10^9 Cells
        1.2.4 Other
    1.3 Market Segmentation by Application
        1.3.1 Global Human NK Cell Isolation Kit Market Size by Application, 2021 vs 2025 vs 2032
        1.3.2 Research Institute
        1.3.3 School
        1.3.4 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global Human NK Cell Isolation Kit Revenue Estimates and Forecasts (2021-2032)
    2.2 Global Human NK Cell Isolation Kit Revenue by Region
        2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
        2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
        2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
    2.3 Global Human NK Cell Isolation Kit Sales Estimates and Forecasts (2021-2032)
    2.4 Global Human NK Cell Isolation Kit Sales by Region
        2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
        2.4.2 Historical and Forecasted Sales by Region (2021-2032)
        2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
        2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
    3.1 Global Human NK Cell Isolation Kit Sales by Manufacturers
        3.1.1 Global Sales Volume by Manufacturers (2021-2026)
        3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
    3.2 Global Human NK Cell Isolation Kit Manufacturer Revenue Rankings and Tiers
        3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
        3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
        3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
    3.3 Manufacturer Profitability Profiles and Pricing Strategies
        3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
        3.3.2 Manufacturer-Level Price Trends (2021-2026)
    3.4 Key Manufacturers Manufacturing Base and Headquarters
    3.5 Key Manufacturers Market Share by Product Type
        3.5.1 1 x 10^8 Cells: Market Share by Key Manufacturers
        3.5.2 1 x 10^9 Cells: Market Share by Key Manufacturers
        3.5.3 Other: Market Share by Key Manufacturers
    3.6 Global Human NK Cell Isolation Kit Market Concentration and Dynamics
        3.6.1 Global Market Concentration
        3.6.2 Entrant/Exit Impact Analysis
        3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
    4.1 Global Human NK Cell Isolation Kit Sales Performance by Type
        4.1.1 Global Human NK Cell Isolation Kit Sales Volume by Type (2021-2032)
        4.1.2 Global Human NK Cell Isolation Kit Revenue by Type (2021-2032)
        4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
    4.2 Product Technology Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Downstream Applications and Customers
    5.1 Global Human NK Cell Isolation Kit Sales by Application
        5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
        5.1.2 Global Sales Market Share by Application (2021-2032)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Global Human NK Cell Isolation Kit Revenue by Application
        5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
        5.2.2 Revenue-Based Market Share by Application (2021-2032)
    5.3 Global Pricing Dynamics by Application (2021-2032)
    5.4 Downstream Customer Analysis
        5.4.1 Top Customers by Region
        5.4.2 Top Customers by Application

6 North America
    6.1 North America Sales Volume and Revenue (2021-2032)
    6.2 North America Key Manufacturers Sales Revenue in 2025
    6.3 North America Human NK Cell Isolation Kit Sales and Revenue by Application (2021-2032)
    6.4 North America Growth Accelerators and Market Barriers
    6.5 North America Human NK Cell Isolation Kit Market Size by Country
        6.5.1 North America Revenue by Country
        6.5.2 North America Sales Trends by Country
        6.5.3 US
        6.5.4 Canada
        6.5.5 Mexico

7 Europe
    7.1 Europe Sales Volume and Revenue (2021-2032)
    7.2 Europe Key Manufacturers Sales Revenue in 2025
    7.3 Europe Human NK Cell Isolation Kit Sales and Revenue by Application (2021-2032)
    7.4 Europe Growth Accelerators and Market Barriers
    7.5 Europe Human NK Cell Isolation Kit Market Size by Country
        7.5.1 Europe Revenue by Country
        7.5.2 Europe Sales Trends by Country
        7.5.3 Germany
        7.5.4 France
        7.5.5 U.K.
        7.5.6 Italy
        7.5.7 Russia

8 Asia-Pacific
    8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
    8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
    8.3 Asia-Pacific Human NK Cell Isolation Kit Sales and Revenue by Application (2021-2032)
    8.4 Asia-Pacific Human NK Cell Isolation Kit Market Size by Region
        8.4.1 Asia-Pacific Revenue by Region
        8.4.2 Asia-Pacific Sales Trends by Region
    8.5 Asia-Pacific Growth Accelerators and Market Barriers
    8.6 Southeast Asia
        8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
        8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
    8.7 China
    8.8 Japan
    8.9 South Korea
    8.10 China Taiwan
    8.11 India

9 Central and South America
    9.1 Central and South America Sales Volume and Revenue (2021-2032)
    9.2 Central and South America Key Manufacturers Sales Revenue in 2025
    9.3 Central and South America Human NK Cell Isolation Kit Sales and Revenue by Application (2021-2032)
    9.4 Central and South America Investment Opportunities and Key Challenges
    9.5 Central and South America Human NK Cell Isolation Kit Market Size by Country
        9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
        9.5.2 Brazil
        9.5.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
    10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
    10.3 Middle East and Africa Human NK Cell Isolation Kit Sales and Revenue by Application (2021-2032)
    10.4 Middle East and Africa Investment Opportunities and Key Challenges
    10.5 Middle East and Africa Human NK Cell Isolation Kit Market Size by Country
        10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
        10.5.2 GCC Countries
        10.5.3 Turkey
        10.5.4 Egypt
        10.5.5 South Africa

11 Corporate Profile
    11.1 BPS Bioscience
        11.1.1 BPS Bioscience Corporation Information
        11.1.2 BPS Bioscience Business Overview
        11.1.3 BPS Bioscience Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.1.4 BPS Bioscience Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.1.5 BPS Bioscience Human NK Cell Isolation Kit Sales by Product in 2025
        11.1.6 BPS Bioscience Human NK Cell Isolation Kit Sales by Application in 2025
        11.1.7 BPS Bioscience Human NK Cell Isolation Kit Sales by Geographic Area in 2025
        11.1.8 BPS Bioscience Human NK Cell Isolation Kit SWOT Analysis
        11.1.9 BPS Bioscience Recent Developments
    11.2 Miltenyi Biotec
        11.2.1 Miltenyi Biotec Corporation Information
        11.2.2 Miltenyi Biotec Business Overview
        11.2.3 Miltenyi Biotec Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.2.4 Miltenyi Biotec Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.2.5 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Product in 2025
        11.2.6 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Application in 2025
        11.2.7 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Geographic Area in 2025
        11.2.8 Miltenyi Biotec Human NK Cell Isolation Kit SWOT Analysis
        11.2.9 Miltenyi Biotec Recent Developments
    11.3 Novus Biologicals
        11.3.1 Novus Biologicals Corporation Information
        11.3.2 Novus Biologicals Business Overview
        11.3.3 Novus Biologicals Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.3.4 Novus Biologicals Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.3.5 Novus Biologicals Human NK Cell Isolation Kit Sales by Product in 2025
        11.3.6 Novus Biologicals Human NK Cell Isolation Kit Sales by Application in 2025
        11.3.7 Novus Biologicals Human NK Cell Isolation Kit Sales by Geographic Area in 2025
        11.3.8 Novus Biologicals Human NK Cell Isolation Kit SWOT Analysis
        11.3.9 Novus Biologicals Recent Developments
    11.4 STEMCELL Technologies
        11.4.1 STEMCELL Technologies Corporation Information
        11.4.2 STEMCELL Technologies Business Overview
        11.4.3 STEMCELL Technologies Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.4.4 STEMCELL Technologies Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.4.5 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Product in 2025
        11.4.6 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Application in 2025
        11.4.7 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Geographic Area in 2025
        11.4.8 STEMCELL Technologies Human NK Cell Isolation Kit SWOT Analysis
        11.4.9 STEMCELL Technologies Recent Developments
    11.5 Thermo Fisher Scientific
        11.5.1 Thermo Fisher Scientific Corporation Information
        11.5.2 Thermo Fisher Scientific Business Overview
        11.5.3 Thermo Fisher Scientific Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.5.4 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.5.5 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Product in 2025
        11.5.6 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Application in 2025
        11.5.7 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Geographic Area in 2025
        11.5.8 Thermo Fisher Scientific Human NK Cell Isolation Kit SWOT Analysis
        11.5.9 Thermo Fisher Scientific Recent Developments
    11.6 RWD
        11.6.1 RWD Corporation Information
        11.6.2 RWD Business Overview
        11.6.3 RWD Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.6.4 RWD Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.6.5 RWD Recent Developments
    11.7 Xinxie Biotechnology
        11.7.1 Xinxie Biotechnology Corporation Information
        11.7.2 Xinxie Biotechnology Business Overview
        11.7.3 Xinxie Biotechnology Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.7.4 Xinxie Biotechnology Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.7.5 Xinxie Biotechnology Recent Developments
    11.8 Jinzhun Biotechnology
        11.8.1 Jinzhun Biotechnology Corporation Information
        11.8.2 Jinzhun Biotechnology Business Overview
        11.8.3 Jinzhun Biotechnology Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.8.4 Jinzhun Biotechnology Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.8.5 Jinzhun Biotechnology Recent Developments
    11.9 R&D Systems
        11.9.1 R&D Systems Corporation Information
        11.9.2 R&D Systems Business Overview
        11.9.3 R&D Systems Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.9.4 R&D Systems Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.9.5 R&D Systems Recent Developments
    11.10 BioLegend
        11.10.1 BioLegend Corporation Information
        11.10.2 BioLegend Business Overview
        11.10.3 BioLegend Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.10.4 BioLegend Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.10.5 BioLegend Recent Developments
    11.11 Proteintech Group
        11.11.1 Proteintech Group Corporation Information
        11.11.2 Proteintech Group Business Overview
        11.11.3 Proteintech Group Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.11.4 Proteintech Group Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.11.5 Proteintech Group Recent Developments
    11.12 Stemery
        11.12.1 Stemery Corporation Information
        11.12.2 Stemery Business Overview
        11.12.3 Stemery Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.12.4 Stemery Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.12.5 Stemery Recent Developments
    11.13 Creative Bioarray
        11.13.1 Creative Bioarray Corporation Information
        11.13.2 Creative Bioarray Business Overview
        11.13.3 Creative Bioarray Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.13.4 Creative Bioarray Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.13.5 Creative Bioarray Recent Developments
    11.14 LubioScience
        11.14.1 LubioScience Corporation Information
        11.14.2 LubioScience Business Overview
        11.14.3 LubioScience Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.14.4 LubioScience Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.14.5 LubioScience Recent Developments
    11.15 Immocell
        11.15.1 Immocell Corporation Information
        11.15.2 Immocell Business Overview
        11.15.3 Immocell Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
        11.15.4 Immocell Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2021-2026)
        11.15.5 Immocell Recent Developments

12 Value Chain and Supply-Chain Analysis
    12.1 Human NK Cell Isolation Kit Industry Chain
    12.2 Human NK Cell Isolation Kit Upstream Materials Analysis
        12.2.1 Raw Materials
        12.2.2 Key Suppliers Market Share & Risk Assessment
    12.3 Human NK Cell Isolation Kit Integrated Production Analysis
        12.3.1 Manufacturing Footprint Analysis
        12.3.2 Regional Production Market Share (2021-2032)
        12.3.3 Regulatory and Trade Policy Impact on Production
        12.3.4 Production Technology Overview
        12.3.5 Regional Cost Drivers
    12.4 Human NK Cell Isolation Kit Sales Channels and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 Human NK Cell Isolation Kit Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints
    13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Human NK Cell Isolation Kit Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Human NK Cell Isolation Kit Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Table 2. Global Human NK Cell Isolation Kit Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Table 3. Global Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 4. Global Human NK Cell Isolation Kit Revenue by Region (US$ Million), 2021-2026
 Table 5. Global Human NK Cell Isolation Kit Revenue by Region (US$ Million), 2027-2032
 Table 6. Global Human NK Cell Isolation Kit Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
 Table 7. Global Human NK Cell Isolation Kit Sales by Region (K Units), 2021-2026
 Table 8. Global Human NK Cell Isolation Kit Sales by Region (K Units), 2027-2032
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 10. Global Human NK Cell Isolation Kit Sales by Manufacturers (K Units), 2021-2026
 Table 11. Global Human NK Cell Isolation Kit Sales Share by Manufacturers (2021-2026)
 Table 12. Global Human NK Cell Isolation Kit Revenue by Manufacturers (US$ Million), 2021-2026
 Table 13. Global Human NK Cell Isolation Kit Revenue-Based Market Share by Manufacturers (2021-2026)
 Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
 Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Human NK Cell Isolation Kit Revenue, 2025
 Table 16. Global Human NK Cell Isolation Kit Average Gross Margin (%) by Manufacturer (2021 vs 2025)
 Table 17. Global Human NK Cell Isolation Kit Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
 Table 18. Key Manufacturers Human NK Cell Isolation Kit Manufacturing Base and Headquarters
 Table 19. Global Human NK Cell Isolation Kit Market Concentration Ratio (CR5)
 Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Human NK Cell Isolation Kit Sales Volume by Type (K Units), 2021-2026
 Table 23. Global Human NK Cell Isolation Kit Sales Volume by Type (K Units), 2027-2032
 Table 24. Global Human NK Cell Isolation Kit Revenue by Type (US$ Million), 2021-2026
 Table 25. Global Human NK Cell Isolation Kit Revenue by Type (US$ Million), 2027-2032
 Table 26. Technical Specifications by Key Product Type
 Table 27. Global Human NK Cell Isolation Kit Sales by Application (K Units), 2021-2026
 Table 28. Global Human NK Cell Isolation Kit Sales by Application (K Units), 2027-2032
 Table 29. Human NK Cell Isolation Kit High-Growth Sectors Demand CAGR (2026-2032)
 Table 30. Global Human NK Cell Isolation Kit Revenue by Application (US$ Million), 2021-2026
 Table 31. Global Human NK Cell Isolation Kit Revenue by Application (US$ Million), 2027-2032
 Table 32. Top Customers by Region
 Table 33. Top Customers by Application
 Table 34. North America Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
 Table 35. North America Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 36. North America Human NK Cell Isolation Kit Sales (K Units) by Country (2021 vs 2025 vs 2032)
 Table 37. Europe Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
 Table 38. Europe Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 39. Europe Human NK Cell Isolation Kit Sales (K Units) by Country (2021 vs 2025 vs 2032)
 Table 40. Asia-Pacific Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Asia-Pacific Human NK Cell Isolation Kit Sales (K Units) by Country (2021 vs 2025 vs 2032)
 Table 42. Asia-Pacific Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
 Table 43. Southeast Asia Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 44. Central and South America Human NK Cell Isolation Kit Investment Opportunities and Key Challenges
 Table 45. Central and South America Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 46. Middle East and Africa Human NK Cell Isolation Kit Investment Opportunities and Key Challenges
 Table 47. Middle East and Africa Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 48. BPS Bioscience Corporation Information
 Table 49. BPS Bioscience Description and Major Businesses
 Table 50. BPS Bioscience Product Models, Descriptions and Specifications
 Table 51. BPS Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 52. BPS Bioscience Sales Value Proportion by Product in 2025
 Table 53. BPS Bioscience Sales Value Proportion by Application in 2025
 Table 54. BPS Bioscience Sales Value Proportion by Geographic Area in 2025
 Table 55. BPS Bioscience Human NK Cell Isolation Kit SWOT Analysis
 Table 56. BPS Bioscience Recent Developments
 Table 57. Miltenyi Biotec Corporation Information
 Table 58. Miltenyi Biotec Description and Major Businesses
 Table 59. Miltenyi Biotec Product Models, Descriptions and Specifications
 Table 60. Miltenyi Biotec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 61. Miltenyi Biotec Sales Value Proportion by Product in 2025
 Table 62. Miltenyi Biotec Sales Value Proportion by Application in 2025
 Table 63. Miltenyi Biotec Sales Value Proportion by Geographic Area in 2025
 Table 64. Miltenyi Biotec Human NK Cell Isolation Kit SWOT Analysis
 Table 65. Miltenyi Biotec Recent Developments
 Table 66. Novus Biologicals Corporation Information
 Table 67. Novus Biologicals Description and Major Businesses
 Table 68. Novus Biologicals Product Models, Descriptions and Specifications
 Table 69. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 70. Novus Biologicals Sales Value Proportion by Product in 2025
 Table 71. Novus Biologicals Sales Value Proportion by Application in 2025
 Table 72. Novus Biologicals Sales Value Proportion by Geographic Area in 2025
 Table 73. Novus Biologicals Human NK Cell Isolation Kit SWOT Analysis
 Table 74. Novus Biologicals Recent Developments
 Table 75. STEMCELL Technologies Corporation Information
 Table 76. STEMCELL Technologies Description and Major Businesses
 Table 77. STEMCELL Technologies Product Models, Descriptions and Specifications
 Table 78. STEMCELL Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 79. STEMCELL Technologies Sales Value Proportion by Product in 2025
 Table 80. STEMCELL Technologies Sales Value Proportion by Application in 2025
 Table 81. STEMCELL Technologies Sales Value Proportion by Geographic Area in 2025
 Table 82. STEMCELL Technologies Human NK Cell Isolation Kit SWOT Analysis
 Table 83. STEMCELL Technologies Recent Developments
 Table 84. Thermo Fisher Scientific Corporation Information
 Table 85. Thermo Fisher Scientific Description and Major Businesses
 Table 86. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 87. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 88. Thermo Fisher Scientific Sales Value Proportion by Product in 2025
 Table 89. Thermo Fisher Scientific Sales Value Proportion by Application in 2025
 Table 90. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2025
 Table 91. Thermo Fisher Scientific Human NK Cell Isolation Kit SWOT Analysis
 Table 92. Thermo Fisher Scientific Recent Developments
 Table 93. RWD Corporation Information
 Table 94. RWD Description and Major Businesses
 Table 95. RWD Product Models, Descriptions and Specifications
 Table 96. RWD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 97. RWD Recent Developments
 Table 98. Xinxie Biotechnology Corporation Information
 Table 99. Xinxie Biotechnology Description and Major Businesses
 Table 100. Xinxie Biotechnology Product Models, Descriptions and Specifications
 Table 101. Xinxie Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 102. Xinxie Biotechnology Recent Developments
 Table 103. Jinzhun Biotechnology Corporation Information
 Table 104. Jinzhun Biotechnology Description and Major Businesses
 Table 105. Jinzhun Biotechnology Product Models, Descriptions and Specifications
 Table 106. Jinzhun Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 107. Jinzhun Biotechnology Recent Developments
 Table 108. R&D Systems Corporation Information
 Table 109. R&D Systems Description and Major Businesses
 Table 110. R&D Systems Product Models, Descriptions and Specifications
 Table 111. R&D Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 112. R&D Systems Recent Developments
 Table 113. BioLegend Corporation Information
 Table 114. BioLegend Description and Major Businesses
 Table 115. BioLegend Product Models, Descriptions and Specifications
 Table 116. BioLegend Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 117. BioLegend Recent Developments
 Table 118. Proteintech Group Corporation Information
 Table 119. Proteintech Group Description and Major Businesses
 Table 120. Proteintech Group Product Models, Descriptions and Specifications
 Table 121. Proteintech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 122. Proteintech Group Recent Developments
 Table 123. Stemery Corporation Information
 Table 124. Stemery Description and Major Businesses
 Table 125. Stemery Product Models, Descriptions and Specifications
 Table 126. Stemery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 127. Stemery Recent Developments
 Table 128. Creative Bioarray Corporation Information
 Table 129. Creative Bioarray Description and Major Businesses
 Table 130. Creative Bioarray Product Models, Descriptions and Specifications
 Table 131. Creative Bioarray Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 132. Creative Bioarray Recent Developments
 Table 133. LubioScience Corporation Information
 Table 134. LubioScience Description and Major Businesses
 Table 135. LubioScience Product Models, Descriptions and Specifications
 Table 136. LubioScience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 137. LubioScience Recent Developments
 Table 138. Immocell Corporation Information
 Table 139. Immocell Description and Major Businesses
 Table 140. Immocell Product Models, Descriptions and Specifications
 Table 141. Immocell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 142. Immocell Recent Developments
 Table 143. Key Raw Materials Distribution
 Table 144. Raw Materials Key Suppliers
 Table 145. Critical Raw Material Supplier Concentration (2025) & Risk Index
 Table 146. Milestones in Production Technology Evolution
 Table 147. Distributors List
 Table 148. Market Trends and Market Evolution
 Table 149. Market Drivers and Opportunities
 Table 150. Market Challenges, Risks, and Restraints
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human NK Cell Isolation Kit Product Picture
 Figure 2. Global Human NK Cell Isolation Kit Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. 1 x 10^8 Cells Product Picture
 Figure 4. 1 x 10^9 Cells Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Human NK Cell Isolation Kit Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 7. Research Institute
 Figure 8. School
 Figure 9. Other
 Figure 10. Human NK Cell Isolation Kit Report Years Considered
 Figure 11. Global Human NK Cell Isolation Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 13. Global Human NK Cell Isolation Kit Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 14. Global Human NK Cell Isolation Kit Revenue-Based Market Share by Region (2021-2032)
 Figure 15. Global Human NK Cell Isolation Kit Sales (K Units), 2021-2032
 Figure 16. Global Human NK Cell Isolation Kit Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
 Figure 17. Global Human NK Cell Isolation Kit Sales Market Share by Region (2021-2032)
 Figure 18. Top 5 and Top 10 Manufacturers Human NK Cell Isolation Kit Sales Volume Market Share in 2025
 Figure 19. Global Human NK Cell Isolation Kit Revenue-Based Market Share Ranking (2025)
 Figure 20. Tier Distribution by Revenue Contribution (2021 vs 2025)
 Figure 21. 1 x 10^8 Cells Revenue-Based Market Share by Manufacturer in 2025
 Figure 22. 1 x 10^9 Cells Revenue-Based Market Share by Manufacturer in 2025
 Figure 23. Other Revenue-Based Market Share by Manufacturer in 2025
 Figure 24. Global Human NK Cell Isolation Kit Sales Volume-Based Market Share by Type (2021-2032)
 Figure 25. Global Human NK Cell Isolation Kit Revenue-Based Market Share by Type (2021-2032)
 Figure 26. Global Human NK Cell Isolation Kit ASP by Type (US$/Unit), 2021-2032
 Figure 27. Global Human NK Cell Isolation Kit Revenue-Based Market Share (2021-2032)
 Figure 28. Global Human NK Cell Isolation Kit Sales Market Share by Application (2021-2032)
 Figure 29. Global Human NK Cell Isolation Kit Revenue-Based Market Share by Application (2021-2032)
 Figure 30. Global Human NK Cell Isolation Kit ASP by Application (US$/Unit), 2021-2032
 Figure 31. North America Human NK Cell Isolation Kit Sales YoY (K Units), 2021-2032
 Figure 32. North America Human NK Cell Isolation Kit Revenue YoY (US$ Million), 2021-2032
 Figure 33. North America Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2025
 Figure 34. North America Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2021-2032)
 Figure 35. North America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 36. US Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 37. Canada Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 38. Mexico Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 39. Europe Human NK Cell Isolation Kit Sales YoY (K Units), 2021-2032
 Figure 40. Europe Human NK Cell Isolation Kit Revenue YoY (US$ Million), 2021-2032
 Figure 41. Europe Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2025
 Figure 42. Europe Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2021-2032)
 Figure 43. Europe Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 44. Germany Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 45. France Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 46. U.K. Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 47. Italy Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 48. Russia Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 49. Asia-Pacific Human NK Cell Isolation Kit Sales YoY (K Units), 2021-2032
 Figure 50. Asia-Pacific Human NK Cell Isolation Kit Revenue YoY (US$ Million), 2021-2032
 Figure 51. Asia-Pacific Top 8 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2025
 Figure 52. Asia-Pacific Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2021-2032)
 Figure 53. Asia-Pacific Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 54. Indonesia Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 55. Japan Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 56. South Korea Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 57. China Taiwan Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 58. India Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 59. Central and South America Human NK Cell Isolation Kit Sales YoY (K Units), 2021-2032
 Figure 60. Central and South America Human NK Cell Isolation Kit Revenue YoY (US$ Million), 2021-2032
 Figure 61. Central and South America Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2025
 Figure 62. Central and South America Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2021-2032)
 Figure 63. Central and South America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 64. Brazil Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 65. Argentina Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 66. Middle East, and Africa Human NK Cell Isolation Kit Sales YoY (K Units), 2021-2032
 Figure 67. Middle East and Africa Human NK Cell Isolation Kit Revenue YoY (US$ Million), 2021-2032
 Figure 68. Middle East and Africa Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2025
 Figure 69. Middle East and Africa Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2021-2032)
 Figure 70. Middle East and Africa Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 71. GCC Countries Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 72. Turkey Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 73. Egypt Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 74. South Africa Human NK Cell Isolation Kit Revenue (US$ Million), 2021-2032
 Figure 75. Human NK Cell Isolation Kit Industry Chain Mapping
 Figure 76. Regional Human NK Cell Isolation Kit Manufacturing Base Distribution (%)
 Figure 77. Global Human NK Cell Isolation Kit Production Market Share by Region (2021-2032)
 Figure 78. Human NK Cell Isolation Kit Production Process
 Figure 79. Regional Human NK Cell Isolation Kit Production Cost Structure
 Figure 80. Channels of Distribution (Direct Vs Distribution)
 Figure 81. Bottom-up and Top-down Approaches for This Report
 Figure 82. Data Triangulation
 Figure 83. Key Executives Interviewed